CTOs on the Move

winter resources

www.winterresources.com

 
winter resources is a Grass Valley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

American Association of Neuromuscular

American Association of Neuromuscular is a Rochester, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Spring Fertility

At Spring, we`re dedicated to helping people bring healthy children into the world. We`re also committed to providing the most personalized, patient-centered and compassionate care, with individualized treatment plans designed for your unique needs.

Affiliated Sante Group

Affiliated Sante Group is a Silver Spring, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Expresso

Expresso fitness headquartered in Santa Clara, CA is the industry leader in gamified fitness for the commercial market. Over the past 15 years, Expresso has brought millions of riders adventure, challenges and community on their world class interactive connected bikes. The company is on a mission to bring people together through fitness with innovative, social, and immersive workouts. With over 100 million workouts where members ride in virtual worlds, push themselves with heart rate training, and HIIT workouts inspired by gaming, the company is well on its way to make that happen.

Immune Pharmaceuticals

Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.